Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensi Seeds is a pioneer in the cannabis seed industry, founded in Amsterdam in 1985 by Ben Dronkers. The company is dedicated to the preservation of cannabis genetics and the development of new, high-quality cannabis strains for both medicinal and recreational use. With a catalog featuring over 500 varieties, Sensi Seeds provides genetics to growers and researchers worldwide, playing a significant role in the expansion of medical cannabis access. In addition to its seed bank operations, the company produces CBD-based oils and hemp-derived supplements through its Sensi CBD and Sensi Seeds Hemp Foods divisions. The company also oversees the Hash Marihuana & Hemp Museum, emphasizing its commitment to the cultural and industrial history of the cannabis plant.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensi Seeds.